Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a

Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului.
N05BE01 BUSPIRONUM COMPR. 10 mg

SPITOMIN 10 mg 10 mg EGIS PHARMACEUTICALS PLC

STRESSIGAL 10 mg ANFARM HELLAS S.A.

PHARMACEUTICALS

N05BE01 BUSPIRONUM COMPR. 5 mg

SPITOMIN 5 mg 5 mg EGIS PHARMACEUTICALS PLC

________________________________________________________________________________
______________________________________________________________________________

| 330 |N06AA21| MAPROTILINUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AA21 MAPROTILINUM COMPR. FILM. 10 mg

LUDIOMIL(R) 10 mg 10 mg NOVARTIS PHARMA GMBH
N06AA21 MAPROTILINUM COMPR. FILM. 25 mg

LUDIOMIL(R) 25 mg 25 mg NOVARTIS PHARMA GMBH

________________________________________________________________________________
______________________________________________________________________________

| 331 |N06AB10| ESCITALOPRAMUM** | Protocol: N009F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AB10 ESCITALOPRAMUM COMPR. FILM. 10 mg

CIPRALEX 10 mg 10 mg H. LUNDBECK A/S
N06AB10 ESCITALOPRAMUM COMPR. FILM. 5 mg

CIPRALEX 5 mg 5 mg H. LUNDBECK A/S

________________________________________________________________________________
______________________________________________________________________________

| 332 |N06AX05| TRAZODONUM** | Protocol: N010F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX05 TRAZODONUM COMPR. ELIB. PREL. 150 mg

TRITTICO AC 150 mg 150 mg ANGELINI FRANCESCO SPA

________________________________________________________________________________

______________________________________________________________________________

| 333 |N06AX14| TIANEPTINUM** | Protocol: N011F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX14 TIANEPTINUM DRAJ. 12.5 mg

COAXIL(R) 12.5 mg LES LAB. SERVIER IND.

________________________________________________________________________________

______________________________________________________________________________

| 334 |N06AX17| MILNACIPRANUM** | Protocol: N002F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX17 MILNACIPRANUM CAPS. 25 mg

IXEL 25 mg PIERRE FABRE MEDICAMENT
N06AX17 MILNACIPRANUM CAPS. 50 mg

IXEL 50 mg PIERRE FABRE MEDICAMENT

________________________________________________________________________________
______________________________________________________________________________

| 335 |N06AX21| DULOXETINUM** | Protocol: N014F |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AX21 DULOXETINUM CAPS. GASTROREZ. 30 mg

CYMBALTA 30 mg 30 mg ELI LILLY NEDERLAND BV
N06AX21 DULOXETINUM SOL. PERF. 100 mg/50 ml

CYMBALTA 60 mg 60 mg ELI LILLY NEDERLAND BV

________________________________________________________________________________
______________________________________________________________________________

| 336 |N06AXN1| BUPROPIONUM**# | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06AXN1 BUPROPIONUM COMPR. FILM. ELIB. PREL. 150 mg

WELLBUTRIN SR 150 mg 150 mg GLAXO WELLCOME UK LTD.

________________________________________________________________________________

______________________________________________________________________________

| 337 |N06BX16| PRAMIRACETAMUM**# | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06BX16 PRAMIRACETAMUM COMPR. FILM. 600 mg

PRAMISTAR 600 mg F.I.R.M.A. S.p.a.

(MENARINI GROUP)

________________________________________________________________________________
______________________________________________________________________________

| 338 |N06BX18| VINPOCETINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N06BX18 VINPOCETINUM COMPR. 10 mg

CAVINTON(R) FORTE 10 mg GEDEON RICHTER LTD.
N06BX18 VINPOCETINUM CAPS. 5 mg

VIMPOCETIN 5 mg 5 mg VIM SPECTRUM SRL

N06BX18 VINPOCETINUM COMPR. 5 mg

CAVINTON(R) 5 mg GEDEON RICHTER LTD.

________________________________________________________________________________
______________________________________________________________________________

| 339 |N07CA01| BETAHISTINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N07CA01 BETAHISTINUM COMPR. 16 mg

BETASERC(R) 16 mg 16 mg SOLVAY PHARMACEUTICALS BV
N07CA01 BETAHISTINUM COMPR. 24 mg

BETASERC(R) 24 mg 24 mg SOLVAY PHARMACEUTICALS BV

N07CA01 BETAHISTINUM COMPR. 80 mg

URUTAL 8 mg 80 mg A & G MED TRADING S.R.L.

N07CA01 BETAHISTINUM COMPR. 8 mg

BETASERC(R) 8 mg 8 mg SOLVAY PHARMACEUTICALS BV

MICROSER 8 mg PRODOTTI FORMENTI

VESTIBO 8 mg 8 mg ACTAVIS GROUP HF.

________________________________________________________________________________
______________________________________________________________________________

| 340 |N07CA52| COMBINATII (CINNARIZINUM + DIMENHIDRATUM) | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N07CA52 COMBINATII COMPR.

(CINNARIZINUM +

DIMENHIDRATUM)

ARLEVERT HENNIG ARZNEIMITTEL GMBH &

CO.KG

________________________________________________________________________________
______________________________________________________________________________

| 341 |N07XN01| HIDROLIZAT DE PROTEINA DIN CREIER DE | Protocol: N026F |

| | | PORCINA** | |

|_______|_______|____________________________________________|_________________|

________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

N07XN01 HIDROLIZAT DE SOL. INJ./PERF. 215.2 mg/ml

PROTEINA DIN CREIER

DE PORCINA

CEREBROLYSIN(R) 215.2 mg/ml EBEWE PHARMA GMBH NFG.KG

________________________________________________________________________________

______________________________________________________________________________

| 342 |P01BA02| HYDROXYCHLOROQUINUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

P01BA02 HYDROXYCHLOROQUINUM COMPR. FILM. 200 mg

PLAQUENIL(R) 200 mg SANOFI-SYNTHELABO LTD.

________________________________________________________________________________

______________________________________________________________________________

| 343 |R03AC04| FENOTEROLUM | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03AC04 FENOTEROLUM SOL. DE INHALAT 100 µg/doză

PRESURIZATĂ

BEROTEC N-100 µg/doză 100 µg/doză BOEHRINGER INGELHEIM

INT. GMBH

________________________________________________________________________________

______________________________________________________________________________

| 344 |R01AD05| BUDESONIDUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________
Prescriere limitată: Profilaxia şi tratamentul rinitei alergice.
R01AD05 BUDESONIDUM SPRAY NAZAL SUSP. 32 µg/doză

RHINOCORT(R) AQUA 32 µg/doză ASTRAZENECA AB

R01AD05 BUDESONIDUM SPRAY NAZ. SUSP. 50 µg/doză

TAFEN NASAL 50 µg/doză LEK PHARMACEUTICALS D.D.

________________________________________________________________________________
______________________________________________________________________________

| 345 |R01AD08| FLUTICASONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________
R01AD08 FLUTICASONUM SPRAY NAZAL SUSP. 50 µg/doză

FLIXONASE(R) 50 µg/doză GLAXOWELLCOME UK LTD.

Prescriere limitată: Profilaxia şi tratamentul rinitei alergice

________________________________________________________________________________

______________________________________________________________________________

| 346 |R01AD09| MOMETASONUM* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R01AD09 MOMETASONUM SPRAY NAZAL SUSP. 50 µg/doză

NASONEX 50 µg/doză SCHERING PLOUGH EUROPE
Prescriere limitată: Profilaxia şi tratamentul rinitei alergice.

Prescriere limitată: Tratamentul polipozelor nazale a adultului.

________________________________________________________________________________
______________________________________________________________________________

| 347 |R03AK03| COMBINATII (FENOTEROLUM + IPRATROPIUM)* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________

R03AK03 COMBINATII AEROSOL SOL. INHAL. 0,020 mg + 0,050 mg

(FENOTEROLUM +

IPRATROPIUM)

BERODUAL(R) N 0,020 mg + 0,050 mg BOEHRINGER INGELHEIM

INT. GMBH

________________________________________________________________________________
______________________________________________________________________________

| 348 |R03AK06| COMBINATII (SALMETEROLUM + FLUTICASONUM)* | |

|_______|_______|____________________________________________|_________________|
________________________________________________________________________________

DCI/DENUMIRE COMERCIALĂ FORMA FARM.

__________________________________________________

CONCENTRAŢIE FIRMA

________________________________________________________________________________
Prescriere limitată: Tratament simptomatic al bolii pulmonare cronice